nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—diaphragm—muscle cancer	0.297	0.506	CbGeAlD
Dantrolene—RYR1—larynx—muscle cancer	0.113	0.192	CbGeAlD
Dantrolene—RYR3—smooth muscle tissue—muscle cancer	0.0273	0.0465	CbGeAlD
Dantrolene—RYR3—tendon—muscle cancer	0.0205	0.0349	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—muscle cancer	0.0196	0.0334	CbGeAlD
Dantrolene—RYR3—vagina—muscle cancer	0.019	0.0324	CbGeAlD
Dantrolene—RYR3—head—muscle cancer	0.0176	0.03	CbGeAlD
Dantrolene—RYR3—testis—muscle cancer	0.017	0.0289	CbGeAlD
Dantrolene—RYR1—tendon—muscle cancer	0.0147	0.0251	CbGeAlD
Dantrolene—RYR1—vagina—muscle cancer	0.0136	0.0233	CbGeAlD
Dantrolene—RYR1—head—muscle cancer	0.0126	0.0215	CbGeAlD
Dantrolene—RYR1—testis—muscle cancer	0.0122	0.0208	CbGeAlD
Dantrolene—Extravasation—Vincristine—muscle cancer	0.00518	0.0125	CcSEcCtD
Dantrolene—Pericarditis—Methotrexate—muscle cancer	0.00507	0.0123	CcSEcCtD
Dantrolene—Aplastic anaemia—Dactinomycin—muscle cancer	0.00475	0.0115	CcSEcCtD
Dantrolene—Hepatotoxicity—Etoposide—muscle cancer	0.00474	0.0115	CcSEcCtD
Dantrolene—Necrosis—Etoposide—muscle cancer	0.00466	0.0113	CcSEcCtD
Dantrolene—Respiratory failure—Vincristine—muscle cancer	0.0046	0.0111	CcSEcCtD
Dantrolene—Pericarditis—Doxorubicin—muscle cancer	0.00439	0.0106	CcSEcCtD
Dantrolene—Phlebitis—Dactinomycin—muscle cancer	0.00426	0.0103	CcSEcCtD
Dantrolene—Extravasation—Etoposide—muscle cancer	0.00419	0.0101	CcSEcCtD
Dantrolene—Hepatic failure—Dactinomycin—muscle cancer	0.00408	0.00988	CcSEcCtD
Dantrolene—Hepatic failure—Vincristine—muscle cancer	0.00365	0.00882	CcSEcCtD
Dantrolene—Eruption—Methotrexate—muscle cancer	0.00356	0.00862	CcSEcCtD
Dantrolene—Pain in extremity—Vincristine—muscle cancer	0.00328	0.00793	CcSEcCtD
Dantrolene—CYP3A4—renal system—muscle cancer	0.00327	0.00558	CbGeAlD
Dantrolene—Dysphagia—Dactinomycin—muscle cancer	0.00317	0.00767	CcSEcCtD
Dantrolene—Urinary retention—Vincristine—muscle cancer	0.00312	0.00754	CcSEcCtD
Dantrolene—Eruption—Doxorubicin—muscle cancer	0.00309	0.00746	CcSEcCtD
Dantrolene—Phlebitis—Etoposide—muscle cancer	0.00308	0.00746	CcSEcCtD
Dantrolene—Swelling—Etoposide—muscle cancer	0.00301	0.00728	CcSEcCtD
Dantrolene—Muscular weakness—Vincristine—muscle cancer	0.00289	0.00699	CcSEcCtD
Dantrolene—Pleural effusion—Methotrexate—muscle cancer	0.00286	0.00692	CcSEcCtD
Dantrolene—Hepatotoxicity—Methotrexate—muscle cancer	0.00284	0.00686	CcSEcCtD
Dantrolene—Necrosis—Methotrexate—muscle cancer	0.00279	0.00675	CcSEcCtD
Dantrolene—Cardiac failure—Etoposide—muscle cancer	0.00272	0.00658	CcSEcCtD
Dantrolene—Speech disorder—Methotrexate—muscle cancer	0.00255	0.00616	CcSEcCtD
Dantrolene—Hepatitis—Dactinomycin—muscle cancer	0.00254	0.00614	CcSEcCtD
Dantrolene—Depression—Vincristine—muscle cancer	0.00252	0.00609	CcSEcCtD
Dantrolene—Extravasation—Methotrexate—muscle cancer	0.00251	0.00608	CcSEcCtD
Dantrolene—Pleural effusion—Doxorubicin—muscle cancer	0.00248	0.00599	CcSEcCtD
Dantrolene—Sweating—Vincristine—muscle cancer	0.00242	0.00586	CcSEcCtD
Dantrolene—Necrosis—Doxorubicin—muscle cancer	0.00242	0.00585	CcSEcCtD
Dantrolene—Flushing—Dactinomycin—muscle cancer	0.00236	0.0057	CcSEcCtD
Dantrolene—Dysphonia—Doxorubicin—muscle cancer	0.00231	0.00558	CcSEcCtD
Dantrolene—Dysphagia—Etoposide—muscle cancer	0.0023	0.00555	CcSEcCtD
Dantrolene—Chills—Dactinomycin—muscle cancer	0.00228	0.00551	CcSEcCtD
Dantrolene—Respiratory failure—Methotrexate—muscle cancer	0.00223	0.0054	CcSEcCtD
Dantrolene—Erythema—Dactinomycin—muscle cancer	0.00221	0.00535	CcSEcCtD
Dantrolene—Extravasation—Doxorubicin—muscle cancer	0.00218	0.00526	CcSEcCtD
Dantrolene—Lacrimation increased—Doxorubicin—muscle cancer	0.00206	0.00498	CcSEcCtD
Dantrolene—Aplastic anaemia—Methotrexate—muscle cancer	0.00206	0.00498	CcSEcCtD
Dantrolene—Ill-defined disorder—Dactinomycin—muscle cancer	0.00205	0.00496	CcSEcCtD
Dantrolene—Nocturia—Doxorubicin—muscle cancer	0.00205	0.00495	CcSEcCtD
Dantrolene—Anaemia—Dactinomycin—muscle cancer	0.00204	0.00494	CcSEcCtD
Dantrolene—Renal failure—Etoposide—muscle cancer	0.00201	0.00487	CcSEcCtD
Dantrolene—Malaise—Dactinomycin—muscle cancer	0.00199	0.00482	CcSEcCtD
Dantrolene—Leukopenia—Dactinomycin—muscle cancer	0.00198	0.00478	CcSEcCtD
Dantrolene—Atrioventricular block—Doxorubicin—muscle cancer	0.00196	0.00473	CcSEcCtD
Dantrolene—Pulmonary oedema—Methotrexate—muscle cancer	0.00195	0.00472	CcSEcCtD
Dantrolene—Back pain—Vincristine—muscle cancer	0.00191	0.00462	CcSEcCtD
Dantrolene—Injection site reaction—Doxorubicin—muscle cancer	0.00189	0.00456	CcSEcCtD
Dantrolene—Myalgia—Dactinomycin—muscle cancer	0.00188	0.00455	CcSEcCtD
Dantrolene—Discomfort—Dactinomycin—muscle cancer	0.00186	0.0045	CcSEcCtD
Dantrolene—Thrombophlebitis—Methotrexate—muscle cancer	0.00184	0.00445	CcSEcCtD
Dantrolene—Anaemia—Vincristine—muscle cancer	0.00183	0.00441	CcSEcCtD
Dantrolene—Aplastic anaemia—Doxorubicin—muscle cancer	0.00178	0.00431	CcSEcCtD
Dantrolene—Hepatic failure—Methotrexate—muscle cancer	0.00177	0.00428	CcSEcCtD
Dantrolene—Leukopenia—Vincristine—muscle cancer	0.00177	0.00427	CcSEcCtD
Dantrolene—Thrombocytopenia—Dactinomycin—muscle cancer	0.00177	0.00427	CcSEcCtD
Dantrolene—Anorexia—Dactinomycin—muscle cancer	0.00172	0.00416	CcSEcCtD
Dantrolene—Convulsion—Vincristine—muscle cancer	0.00171	0.00414	CcSEcCtD
Dantrolene—Flushing—Etoposide—muscle cancer	0.00171	0.00412	CcSEcCtD
Dantrolene—Hypertension—Vincristine—muscle cancer	0.0017	0.00412	CcSEcCtD
Dantrolene—Pulmonary oedema—Doxorubicin—muscle cancer	0.00169	0.00409	CcSEcCtD
Dantrolene—Myalgia—Vincristine—muscle cancer	0.00168	0.00407	CcSEcCtD
Dantrolene—Visual disturbance—Methotrexate—muscle cancer	0.00168	0.00406	CcSEcCtD
Dantrolene—Chills—Etoposide—muscle cancer	0.00165	0.00399	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00164	0.00397	CcSEcCtD
Dantrolene—Anaphylactic shock—Vincristine—muscle cancer	0.00161	0.0039	CcSEcCtD
Dantrolene—Phlebitis—Doxorubicin—muscle cancer	0.0016	0.00387	CcSEcCtD
Dantrolene—Thrombophlebitis—Doxorubicin—muscle cancer	0.00159	0.00385	CcSEcCtD
Dantrolene—Thrombocytopenia—Vincristine—muscle cancer	0.00158	0.00382	CcSEcCtD
Dantrolene—Decreased appetite—Dactinomycin—muscle cancer	0.00157	0.00379	CcSEcCtD
Dantrolene—Dysgeusia—Etoposide—muscle cancer	0.00157	0.00379	CcSEcCtD
Dantrolene—Hyperhidrosis—Vincristine—muscle cancer	0.00156	0.00377	CcSEcCtD
Dantrolene—Fatigue—Dactinomycin—muscle cancer	0.00156	0.00376	CcSEcCtD
Dantrolene—Back pain—Etoposide—muscle cancer	0.00155	0.00374	CcSEcCtD
Dantrolene—Pain—Dactinomycin—muscle cancer	0.00154	0.00373	CcSEcCtD
Dantrolene—Anorexia—Vincristine—muscle cancer	0.00154	0.00372	CcSEcCtD
Dantrolene—Hepatic failure—Doxorubicin—muscle cancer	0.00153	0.00371	CcSEcCtD
Dantrolene—Feeling abnormal—Dactinomycin—muscle cancer	0.00149	0.00359	CcSEcCtD
Dantrolene—Ill-defined disorder—Etoposide—muscle cancer	0.00148	0.00359	CcSEcCtD
Dantrolene—Anaemia—Etoposide—muscle cancer	0.00148	0.00358	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00148	0.00357	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00147	0.00355	CcSEcCtD
Dantrolene—Insomnia—Vincristine—muscle cancer	0.00146	0.00353	CcSEcCtD
Dantrolene—Malaise—Etoposide—muscle cancer	0.00144	0.00349	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—muscle cancer	0.00143	0.00346	CcSEcCtD
Dantrolene—Body temperature increased—Dactinomycin—muscle cancer	0.00143	0.00345	CcSEcCtD
Dantrolene—Abdominal pain—Dactinomycin—muscle cancer	0.00143	0.00345	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—muscle cancer	0.00141	0.00341	CcSEcCtD
Dantrolene—Decreased appetite—Vincristine—muscle cancer	0.0014	0.00339	CcSEcCtD
Dantrolene—Fatigue—Vincristine—muscle cancer	0.00139	0.00336	CcSEcCtD
Dantrolene—Convulsion—Etoposide—muscle cancer	0.00139	0.00335	CcSEcCtD
Dantrolene—Hypertension—Etoposide—muscle cancer	0.00138	0.00334	CcSEcCtD
Dantrolene—Pain—Vincristine—muscle cancer	0.00138	0.00333	CcSEcCtD
Dantrolene—Constipation—Vincristine—muscle cancer	0.00138	0.00333	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—muscle cancer	0.00138	0.00333	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—muscle cancer	0.00138	0.00333	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00138	0.00333	CcSEcCtD
Dantrolene—Eosinophilia—Methotrexate—muscle cancer	0.00136	0.00329	CcSEcCtD
Dantrolene—Discomfort—Etoposide—muscle cancer	0.00135	0.00325	CcSEcCtD
Dantrolene—Hypersensitivity—Dactinomycin—muscle cancer	0.00133	0.00321	CcSEcCtD
Dantrolene—Gastrointestinal pain—Vincristine—muscle cancer	0.00132	0.00319	CcSEcCtD
Dantrolene—Confusional state—Etoposide—muscle cancer	0.00132	0.00318	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—muscle cancer	0.00131	0.00316	CcSEcCtD
Dantrolene—Asthenia—Dactinomycin—muscle cancer	0.00129	0.00313	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—muscle cancer	0.00128	0.00309	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—muscle cancer	0.00127	0.00308	CcSEcCtD
Dantrolene—Abdominal pain—Vincristine—muscle cancer	0.00127	0.00308	CcSEcCtD
Dantrolene—Body temperature increased—Vincristine—muscle cancer	0.00127	0.00308	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—muscle cancer	0.00126	0.00305	CcSEcCtD
Dantrolene—Anorexia—Etoposide—muscle cancer	0.00124	0.00301	CcSEcCtD
Dantrolene—Diarrhoea—Dactinomycin—muscle cancer	0.00123	0.00298	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—muscle cancer	0.00123	0.00297	CcSEcCtD
Dantrolene—Depression—Methotrexate—muscle cancer	0.00122	0.00296	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—muscle cancer	0.00122	0.00294	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—muscle cancer	0.00121	0.00291	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—muscle cancer	0.00119	0.00288	CcSEcCtD
Dantrolene—Hypersensitivity—Vincristine—muscle cancer	0.00119	0.00287	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—muscle cancer	0.00118	0.00285	CcSEcCtD
Dantrolene—Sweating—Methotrexate—muscle cancer	0.00118	0.00284	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—muscle cancer	0.00117	0.00283	CcSEcCtD
Dantrolene—Somnolence—Etoposide—muscle cancer	0.00116	0.00281	CcSEcCtD
Dantrolene—Asthenia—Vincristine—muscle cancer	0.00116	0.0028	CcSEcCtD
Dantrolene—Vomiting—Dactinomycin—muscle cancer	0.00115	0.00277	CcSEcCtD
Dantrolene—Rash—Dactinomycin—muscle cancer	0.00114	0.00275	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—muscle cancer	0.00113	0.00274	CcSEcCtD
Dantrolene—Fatigue—Etoposide—muscle cancer	0.00113	0.00272	CcSEcCtD
Dantrolene—Pain—Etoposide—muscle cancer	0.00112	0.0027	CcSEcCtD
Dantrolene—Constipation—Etoposide—muscle cancer	0.00112	0.0027	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—muscle cancer	0.00111	0.00268	CcSEcCtD
Dantrolene—Diarrhoea—Vincristine—muscle cancer	0.0011	0.00267	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—muscle cancer	0.0011	0.00266	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—muscle cancer	0.0011	0.00266	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—muscle cancer	0.0011	0.00266	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—muscle cancer	0.00108	0.0026	CcSEcCtD
Dantrolene—Nausea—Dactinomycin—muscle cancer	0.00107	0.00259	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—muscle cancer	0.00107	0.00258	CcSEcCtD
Dantrolene—Dizziness—Vincristine—muscle cancer	0.00107	0.00258	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—muscle cancer	0.00106	0.00257	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—muscle cancer	0.00106	0.00257	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—muscle cancer	0.00104	0.00252	CcSEcCtD
Dantrolene—Urticaria—Etoposide—muscle cancer	0.00104	0.00251	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—muscle cancer	0.00103	0.0025	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—muscle cancer	0.00103	0.0025	CcSEcCtD
Dantrolene—Vomiting—Vincristine—muscle cancer	0.00102	0.00248	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—muscle cancer	0.00102	0.00246	CcSEcCtD
Dantrolene—Rash—Vincristine—muscle cancer	0.00102	0.00246	CcSEcCtD
Dantrolene—Dermatitis—Vincristine—muscle cancer	0.00102	0.00246	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—muscle cancer	0.00101	0.00245	CcSEcCtD
Dantrolene—Headache—Vincristine—muscle cancer	0.00101	0.00244	CcSEcCtD
Dantrolene—Chills—Methotrexate—muscle cancer	0.000988	0.00239	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—muscle cancer	0.000962	0.00233	CcSEcCtD
Dantrolene—Erythema—Methotrexate—muscle cancer	0.000958	0.00232	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—muscle cancer	0.000958	0.00232	CcSEcCtD
Dantrolene—Nausea—Vincristine—muscle cancer	0.000957	0.00232	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—muscle cancer	0.000953	0.00231	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—muscle cancer	0.000953	0.00231	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—muscle cancer	0.000938	0.00227	CcSEcCtD
Dantrolene—Asthenia—Etoposide—muscle cancer	0.000937	0.00227	CcSEcCtD
Dantrolene—Back pain—Methotrexate—muscle cancer	0.000927	0.00224	CcSEcCtD
Dantrolene—Pruritus—Etoposide—muscle cancer	0.000924	0.00223	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—muscle cancer	0.000918	0.00222	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—muscle cancer	0.000903	0.00218	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—muscle cancer	0.000893	0.00216	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—muscle cancer	0.000889	0.00215	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—muscle cancer	0.000886	0.00214	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—muscle cancer	0.000885	0.00214	CcSEcCtD
Dantrolene—Malaise—Methotrexate—muscle cancer	0.000864	0.00209	CcSEcCtD
Dantrolene—Dizziness—Etoposide—muscle cancer	0.000863	0.00209	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—muscle cancer	0.000858	0.00207	CcSEcCtD
Dantrolene—Chills—Doxorubicin—muscle cancer	0.000855	0.00207	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—muscle cancer	0.00083	0.00201	CcSEcCtD
Dantrolene—Vomiting—Etoposide—muscle cancer	0.00083	0.00201	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—muscle cancer	0.00083	0.00201	CcSEcCtD
Dantrolene—Rash—Etoposide—muscle cancer	0.000823	0.00199	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—muscle cancer	0.000822	0.00199	CcSEcCtD
Dantrolene—Headache—Etoposide—muscle cancer	0.000818	0.00198	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—muscle cancer	0.000816	0.00197	CcSEcCtD
Dantrolene—Tension—Doxorubicin—muscle cancer	0.000814	0.00197	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—muscle cancer	0.000812	0.00196	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—muscle cancer	0.000806	0.00195	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—muscle cancer	0.000806	0.00195	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—muscle cancer	0.000803	0.00194	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—muscle cancer	0.000788	0.00191	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—muscle cancer	0.000782	0.00189	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—muscle cancer	0.000782	0.00189	CcSEcCtD
Dantrolene—Nausea—Etoposide—muscle cancer	0.000775	0.00188	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—muscle cancer	0.00077	0.00186	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—muscle cancer	0.000767	0.00185	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—muscle cancer	0.000766	0.00185	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—muscle cancer	0.000756	0.00183	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—muscle cancer	0.000748	0.00181	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—muscle cancer	0.000745	0.0018	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—muscle cancer	0.000743	0.0018	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—muscle cancer	0.000719	0.00174	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—muscle cancer	0.000716	0.00173	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000712	0.00172	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—muscle cancer	0.000707	0.00171	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—muscle cancer	0.000706	0.00171	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—muscle cancer	0.000698	0.00169	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—muscle cancer	0.000695	0.00168	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—muscle cancer	0.000691	0.00167	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—muscle cancer	0.000688	0.00166	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—muscle cancer	0.000683	0.00165	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—muscle cancer	0.00068	0.00164	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—muscle cancer	0.000677	0.00164	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—muscle cancer	0.000674	0.00163	CcSEcCtD
Dantrolene—Pain—Methotrexate—muscle cancer	0.000669	0.00162	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—muscle cancer	0.000663	0.0016	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—muscle cancer	0.000661	0.0016	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—muscle cancer	0.000655	0.00158	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—muscle cancer	0.000645	0.00156	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—muscle cancer	0.000644	0.00156	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—muscle cancer	0.000639	0.00155	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—muscle cancer	0.000621	0.0015	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—muscle cancer	0.000618	0.0015	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—muscle cancer	0.000618	0.0015	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000617	0.00149	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—muscle cancer	0.000612	0.00148	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—muscle cancer	0.000602	0.00146	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—muscle cancer	0.000596	0.00144	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—muscle cancer	0.000589	0.00142	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—muscle cancer	0.000584	0.00141	CcSEcCtD
Dantrolene—Pain—Doxorubicin—muscle cancer	0.000579	0.0014	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—muscle cancer	0.000579	0.0014	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—muscle cancer	0.000576	0.00139	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—muscle cancer	0.000561	0.00136	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—muscle cancer	0.000558	0.00135	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000554	0.00134	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—muscle cancer	0.000553	0.00134	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—muscle cancer	0.000538	0.0013	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—muscle cancer	0.000535	0.00129	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—muscle cancer	0.000535	0.00129	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—muscle cancer	0.000535	0.00129	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—muscle cancer	0.000517	0.00125	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—muscle cancer	0.000499	0.00121	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—muscle cancer	0.000497	0.0012	CcSEcCtD
Dantrolene—Rash—Methotrexate—muscle cancer	0.000493	0.00119	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—muscle cancer	0.000493	0.00119	CcSEcCtD
Dantrolene—Headache—Methotrexate—muscle cancer	0.00049	0.00118	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—muscle cancer	0.000486	0.00117	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—muscle cancer	0.000479	0.00116	CcSEcCtD
Dantrolene—Nausea—Methotrexate—muscle cancer	0.000464	0.00112	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—muscle cancer	0.000463	0.00112	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—muscle cancer	0.000448	0.00108	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—muscle cancer	0.000431	0.00104	CcSEcCtD
Dantrolene—Rash—Doxorubicin—muscle cancer	0.000427	0.00103	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—muscle cancer	0.000427	0.00103	CcSEcCtD
Dantrolene—Headache—Doxorubicin—muscle cancer	0.000424	0.00103	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—muscle cancer	0.000402	0.000973	CcSEcCtD
